01228.HK
CANbridge Pharmaceuticals Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 1.92
−0.52%Jul 30, 2026, 09:29 UTC
Canbridge Pharmaceuticals has initiated the registration process and commercialization preparations for its drug Velafermin β in key North African markets.
Source: